Johns Hopkins Medicine: U.S. Study of Intravenous Mistletoe Extract to Treat Advanced Cancer
February 23, 2023
February 23, 2023
BALTIMORE, Maryland, Feb. 23 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials and data to support its use. Researchers at the Johns Hopkins Kimmel Cancer Center completed what is believed to be the first phase I trial of intravenous Helixor M in the U.S. aimed at determining dosing for subsequent clinical trials and to evalua . . .
Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials and data to support its use. Researchers at the Johns Hopkins Kimmel Cancer Center completed what is believed to be the first phase I trial of intravenous Helixor M in the U.S. aimed at determining dosing for subsequent clinical trials and to evalua . . .